亚狮康药业(ASLN)

产业链观察2023-07-06 20:17

#药闻简讯# 2023年7月6日，以免疫学为重点的临床阶段生物公司$亚狮康药业(ASLN)$ 今天宣布了其对中重度特应性皮炎（AD）成年患者进行的2b期剂量范围研究TREK-AD（TRials with EblasaKimab in Atopic Dermatitis）的积极顶线数据。
Eblasakimab在第16周与安慰剂相比达到了湿疹面积和严重程度指...查看全文

年度财报

亚狮康药业(ASLN)2023-03-24 19:36

$亚狮康药业(ASLN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0000950170-23-009599  Act: 34  Size: 25 MB 网页链接查看全文

小小的dream2023-01-05 00:08

$亚狮康药业(ASLN)$ 临床2期成功，为3期准备了？靶向IL13R的单抗，皮下高浓度有很大依从性优势。查看全文

财报披露

亚狮康药业(ASLN)04-12 18:15

$亚狮康药业(ASLN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-043852  Act: 34  Size: 386 KB 网页链接查看全文

财报披露

亚狮康药业(ASLN)04-12 20:15

$亚狮康药业(ASLN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-043871  Act: 34  Size: 110 KB 网页链接查看全文

年度财报

亚狮康药业(ASLN)04-12 18:35

$亚狮康药业(ASLN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0000950170-24-043860  Act: 34  Size: 22 MB 网页链接查看全文

员工持股计划

亚狮康药业(ASLN)04-12 18:45

$亚狮康药业(ASLN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-043862  Act: 33  Size: 208 KB 网页链接查看全文

招股说明书

亚狮康药业(ASLN)04-12 20:25

$亚狮康药业(ASLN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0000950170-24-043873  Act: 33  Size: 1 MB 网页链接查看全文

生效批准

亚狮康药业(ASLN)04-01 18:05

$亚狮康药业(ASLN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000801  Act: 33  Size: 1 KB 网页链接查看全文

发行公告

亚狮康药业(ASLN)03-29 02:15

$亚狮康药业(ASLN)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001722926-24-000001  Act: 33  Size: 13 KB 网页链接查看全文

招股说明书

$亚狮康药业(ASLN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0000950170-24-043873  Act: 33  Size: 1 MB 网页链接

财报披露

$亚狮康药业(ASLN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-043871  Act: 34  Size: 110 KB 网页链接

员工持股计划

$亚狮康药业(ASLN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-043862  Act: 33  Size: 208 KB 网页链接

年度财报

$亚狮康药业(ASLN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0000950170-24-043860  Act: 34  Size: 22 MB 网页链接

财报披露

$亚狮康药业(ASLN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-043852  Act: 34  Size: 386 KB 网页链接

生效批准

$亚狮康药业(ASLN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000801  Act: 33  Size: 1 KB 网页链接

发行公告

$亚狮康药业(ASLN)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001722926-24-000001  Act: 33  Size: 13 KB 网页链接

增发股票注册声明

$亚狮康药业(ASLN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001193125-24-076568  Act: 33  Size: 470 KB 网页链接

超过5%股东持股披露

$亚狮康药业(ASLN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-024796  Act: 34  Size: 67 KB 网页链接

超过5%股东持股披露

$亚狮康药业(ASLN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-001052  Act: 34  Size: 70 KB 网页链接